| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.87B | 2.90B | 2.98B | 2.55B | 2.00B | 1.95B |
| Gross Profit | 1.23B | 1.24B | 1.32B | 1.10B | 832.00M | 831.40M |
| EBITDA | 301.10M | 320.20M | 447.60M | 379.80M | 240.30M | 262.10M |
| Net Income | 157.40M | 152.60M | 284.80M | 230.00M | 125.50M | 154.70M |
Balance Sheet | ||||||
| Total Assets | 2.66B | 2.62B | 2.54B | 2.10B | 1.85B | 1.62B |
| Cash, Cash Equivalents and Short-Term Investments | 219.20M | 147.70M | 260.30M | 257.90M | 197.90M | 200.80M |
| Total Debt | 552.60M | 511.90M | 373.30M | 299.90M | 321.00M | 391.60M |
| Total Liabilities | 1.27B | 1.27B | 1.20B | 990.20M | 943.80M | 894.80M |
| Stockholders Equity | 1.39B | 1.35B | 1.34B | 1.11B | 899.40M | 719.90M |
Cash Flow | ||||||
| Free Cash Flow | 246.00M | 209.80M | 260.40M | 160.50M | 132.90M | 72.40M |
| Operating Cash Flow | 266.70M | 259.10M | 306.50M | 203.00M | 187.60M | 147.10M |
| Investing Cash Flow | -46.30M | -57.70M | -270.50M | -40.30M | -190.20M | -74.90M |
| Financing Cash Flow | -254.00M | -185.40M | -79.60M | -94.60M | 66.00M | -95.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £2.65B | 8.02 | 11.47% | 3.58% | -2.44% | -6.43% | |
73 Outperform | £8.35B | 38.47 | 14.17% | 1.13% | 11.82% | 42.93% | |
68 Neutral | £1.71B | 13.32 | 8.38% | 3.99% | 5.75% | 5.86% | |
64 Neutral | £191.94M | 0.64 | 7.92% | 6.53% | ― | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
50 Neutral | £34.60M | -10.98 | -64.09% | ― | -0.25% | -84.33% | |
47 Neutral | £98.10M | -1.82 | -47.73% | ― | -2.08% | -9.83% |